Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
595 patients, 120 (20 %) had high social vulnerability.
I · Intervention 중재 / 시술
upfront surgery between 2011 and 2021 in a single health care system
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Delay is subsequently associated with pathologic upstaging. These findings warrant interventions for vulnerable patients to promote equitable surgical care.
[BACKGROUND] Timely surgical resection is an important component of treatment for non-small cell lung cancer (NSCLC).
- p-value p < 0.001
APA
Mott NM, Meguid RA, et al. (2026). Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.. Annals of surgical oncology, 33(2), 858-870. https://doi.org/10.1245/s10434-025-18337-y
MLA
Mott NM, et al.. "Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stages IA to IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.." Annals of surgical oncology, vol. 33, no. 2, 2026, pp. 858-870.
PMID
40975736 ↗
Abstract 한글 요약
[BACKGROUND] Timely surgical resection is an important component of treatment for non-small cell lung cancer (NSCLC). The Social Vulnerability Index (SVI) is a validated, composite metric for social determinants of health. This study aimed to determine whether social vulnerability is associated with delayed surgery for NSCLC.
[METHODS] The study identified patients with stages IA to IIIA NSCLC who underwent upfront surgery between 2011 and 2021 in a single health care system. High social vulnerability was defined as SVI ≥ 75th percentile. Delayed surgery was defined as longer than 9 weeks after diagnosis. Unadjusted and risk-adjusted predictors of delayed surgery were identified. Time to surgery also was analyzed as a continuous variable. A negative binomial model was fitted to assess the individual impact of social vulnerability on time to surgery in days.
[RESULTS] Of 595 patients, 120 (20 %) had high social vulnerability. A greater proportion of vulnerable patients experienced surgical delay (32 % vs 16 %; p < 0.001) and had a significantly longer time to surgery (median, 49 days [interquartile range {IQR}, 19-84 days] vs 32 days [IQR, 0-57 days]; p < 0.001). After risk adjustment, high social vulnerability was associated with 2.3 times higher odds of surgical delay (95 % confidence interval [CI], 1.4-3.7), and vulnerable patients waited a risk-adjusted median of 29 days longer for surgery. Surgical delay was significantly associated with pathologic upstaging (43 % vs 23 %; p < 0.001).
[CONCLUSIONS] High social vulnerability is associated with surgical delay in NSCLC, even after controlling for demographic and clinical factors. Delay is subsequently associated with pathologic upstaging. These findings warrant interventions for vulnerable patients to promote equitable surgical care.
[METHODS] The study identified patients with stages IA to IIIA NSCLC who underwent upfront surgery between 2011 and 2021 in a single health care system. High social vulnerability was defined as SVI ≥ 75th percentile. Delayed surgery was defined as longer than 9 weeks after diagnosis. Unadjusted and risk-adjusted predictors of delayed surgery were identified. Time to surgery also was analyzed as a continuous variable. A negative binomial model was fitted to assess the individual impact of social vulnerability on time to surgery in days.
[RESULTS] Of 595 patients, 120 (20 %) had high social vulnerability. A greater proportion of vulnerable patients experienced surgical delay (32 % vs 16 %; p < 0.001) and had a significantly longer time to surgery (median, 49 days [interquartile range {IQR}, 19-84 days] vs 32 days [IQR, 0-57 days]; p < 0.001). After risk adjustment, high social vulnerability was associated with 2.3 times higher odds of surgical delay (95 % confidence interval [CI], 1.4-3.7), and vulnerable patients waited a risk-adjusted median of 29 days longer for surgery. Surgical delay was significantly associated with pathologic upstaging (43 % vs 23 %; p < 0.001).
[CONCLUSIONS] High social vulnerability is associated with surgical delay in NSCLC, even after controlling for demographic and clinical factors. Delay is subsequently associated with pathologic upstaging. These findings warrant interventions for vulnerable patients to promote equitable surgical care.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Carcinoma
- Non-Small-Cell Lung
- Lung Neoplasms
- Female
- Male
- Middle Aged
- Aged
- Neoplasm Staging
- Time-to-Treatment
- Prognosis
- Follow-Up Studies
- Pneumonectomy
- Social Determinants of Health
- Vulnerable Populations
- Retrospective Studies
- Survival Rate
- NSCLC
- Non-small cell lung cancer
- Pathologic upstaging
- SVI
- Social vulnerability index
- Surgery
- Time to surgery
… 외 1개
같은 제1저자의 인용 많은 논문 (3)
- Securing Lung Cancer Screening, The First Step.
- ASO Visual Abstract: Social Vulnerability is Associated with Significant Delays to Definitive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer and Consequential Increased Rates of Pathologic Upstaging.
- ASO Author Reflections: Social Vulnerability and Surgical Delay in Resectable Non-small Cell Lung Cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.